In addition to CD49d, the clinical significance of CD49f in childhood BCP‐ALL has been highlighted by a recent comprehensive clinical study in which CD49f expression was associated with persistent minimal residual disease (MRD).18 This evidence concerns the gene ITGA6 and acute lymphoblastic leukemia.